TABLE 1.
Age and Dose | Number Vaccinated* as of 6/11/21 | Females | Males | ||||
---|---|---|---|---|---|---|---|
Expected | Observed | Myo/pericarditis per Million Vaccinated (95% CI) | Expected | Observed | Myo/pericarditis per Million Vaccinated (95% CI) | ||
12–15 | |||||||
Dose 1 | 3,669,373 | 1.35 | 0 | 0.0 (0.0‐0.2) | 2.12 | 21 | 11.4 (7.09, 17.5) |
Dose 2 | 1,233,021 | 1.35 | 8 | 13.0 (5.6, 25.6) | 2.12 | 100 | 162.2 (132.0, 197.3) |
16–17 | |||||||
Dose 1 | 2,943,756 | 1.35 | 2 | 1.4 (0.2, 4.9) | 2.12 | 12 | 8.2 (4.21, 14.2) |
Dose 2 | 2,085,725 | 1.35 | 13 | 12.5 (6.6, 21.3) | 2.12 | 97 | 93.0 (75.4, 113.5) |
12–17 | |||||||
Dose 1 | 6,613,129 | 1.35 | 2 | 0.6 (0.1, 2.2) | 2.12 | 33 | 10.0 (6.9, 14.0) |
Dose 2 | 3,318,746 | 1.35 | 21 | 12.7 (7.8, 19.3) | 2.12 | 197 | 118.7 (102.7, 136.5) |
Number vaccinated is divided by two to compute male and female rates per million.